Recent Developments at Regeneron in Westchester

Regeneron Pharmaceuticals, based in Tarrytown, Westchester County, has been making significant strides in expanding its operations and contributing to the local economy. Here are some of the notable recent developments:

Major Expansion Projects

$1.8 Billion Campus Expansion: Regeneron is investing $1.8 billion in a major expansion of its Tarrytown campus. This project, approved by the Westchester County Industrial Development Agency, aims to create over 2,700 new construction jobs and around 1,000 permanent positions. The expansion will add more than 900,000 square feet, including new buildings for labs, manufacturing, development suites, and administrative spaces. This initiative is expected to generate approximately $357 million in economic activity for the county​ (New York YIMBY)​​ (Rivertowns News)​.

$1.39 Billion Phase 2 Expansion: In addition to the larger $1.8 billion project, Regeneron is also moving forward with a $1.39 billion expansion, which will create at least 700 new full-time jobs and nearly 800 construction jobs. This phase involves constructing a 724,000-square-foot facility to further support their research and development efforts​ (Rivertowns News)​.

Innovative Collaborations and Projects

Smart Windows Adoption: Regeneron is embracing high-tech solutions by being one of the early adopters of smart windows with an internal electrochromic coating. These windows help control light and heat, enhancing energy efficiency and comfort within their facilities​ (New York YIMBY)​.

Allogenic Cell Therapy Research: Regeneron has teamed up with Celularity Inc., a biotechnology company based in New Jersey, to advance research in allogenic cell therapy. This collaboration focuses on developing innovative treatments for various diseases, showcasing Regeneron’s commitment to pioneering medical research​ (New York YIMBY)​.

Economic and Community Impact

The expansion projects and innovative collaborations underscore Regeneron’s role as a major employer and economic driver in Westchester. With over 3,300 full-time employees already at its Tarrytown headquarters, the company’s growth promises substantial economic benefits, including significant tax revenue and increased local spending​ (Rivertowns News)​.

Regeneron’s ongoing projects and expansions in Westchester highlight its commitment to growth, innovation, and community development. The investments not only boost the local economy but also reinforce Regeneron’s position as a leader in the biotechnology sector, driving forward significant advancements in medical research and treatment.